Adaptimmune
Series AAdaptimmune raised €79M in a Series A round in Sep 2014. The company is based in Milton, UK. Investors in the round: New Enterprise Associates, Novo A, S and 1 other. Data as of Nov 2026.
Amount raised
€79M
€78,859,569
Native amount
104,000,000 USD
Stage
Series A
series a
Investors
4
Provenance & confidence
UnverifiedAmount
104,000,000 USD
ECB-at-date → €79M · rate 1.3188 on 2014-08-29
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Sep 2014
Round type
series a
Amount (EUR)
€79M
Other rounds
same companyThis is the company's only recorded round.